Literature DB >> 6280576

Levels of adenosine 3',5' cyclic monophosphate and guanosine 3',5' cyclic monophosphate in single urine specimens collected from a large population of healthy subjects.

G A Turner, R D Ellis, D Guthrie, A L Latner, A W Skillen, W M Ross.   

Abstract

The levels of adenosine 3',5' cyclic monophosphate and guanosine 3',5' cyclic monophosphate have been measured in random urine specimens provided by 95 healthy volunteers with a view to assessing the importance of the effects of certain physiological factors on the cyclic nucleotide levels in this type of specimen, and to establish suitable reference ranges for future patient monitoring studies. Of the factors investigated, only the stage of the menstrual cycle was found to have a significant effect; even this variation was still within the overall normal reference range. Measurements of urine cyclic nucleotides were also made in relation to the method of specimen collection, handling, and storage. From these studies it was concluded that if the specimen is placed in a refrigerator within a few hours of collection and then transferred to a deep-freeze within 48 hours, these factors do not present any major problems for the subsequent assay of the cyclic nucleotides.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6280576     DOI: 10.1177/000456328201900203

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  2 in total

1.  Urine cyclic nucleotide concentrations in cancer and other conditions; cyclic GMP: a potential marker for cancer treatment.

Authors:  G A Turner; R D Ellis; D Guthrie; A L Latner; J M Monaghan; W M Ross; A W Skillen; R G Wilson
Journal:  J Clin Pathol       Date:  1982-08       Impact factor: 3.411

2.  cGMP levels in chronic cadmium disease and osteoarthritis.

Authors:  S Kagamimori; W R Williams; M Watanabe
Journal:  Br J Exp Pathol       Date:  1986-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.